Nature Reviews Urology

Article	Citations
Novel intravesical gemcitabine delivery system (TAR-200) for neoadjuvant treatment of MIBC: context is everything	215
Texture analysis for patient selection	202
Single-cell and spatial sequencing of kidney cancer	149
Human-relevant urothelial model provides insight into infection strategies and host response	135
Krause corpuscles act as genital vibration detectors	108
Semen quality recovery following COVID-19	100
PARP inhibitors plus enzalutamide to treat mCRPC	83
High-dose chemotherapy for relapsed testicular germ cell tumours	79
Urine microbiota differ in bladder cancer	77
Considering urology in a planetary context	76
Preclinical models of bladder cancer: BBN and beyond	73
Time for women-centred gynaecology	73
A clinical guide to rare male sexual disorders	69
Advancing the state of the art in congenital obstructive uropathy	69
Micro-ultrasound for prostate cancer	65
Symptoms and subtypes of patients with lower urinary tract dysfunction — insights from the Symptoms of Lower Urinary Tract Dysfunction Research Network	64
Proteomic-based analysis of testicular interstitial fluid	61
FOXA2–KIT-driven lineage plasticity in NEPC	58
A new text message-based platform for self-management of patients with IC/BPS	55
Overcoming antibiotic resistance in complicated UTI	55
Madrid plays host to a celebration of urology	53
Microfluidic sperm selection	53
What happens in Vegas … shapes the future of urology	53
The evolving landscape of monogenic nephrolithiasis and therapeutic innovations	52
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer	52

Promise without practice — charting the path forward for bladder cancer biomarkers	51
Leveraging generative AI to enhance doctor–patient communication	51
Antibiotic therapy for treating overactive bladder is not supported by clinical evidence	47
Metaverse in surgery — origins and future potential	47
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers	47
Pembrolizumab + axitinib beyond first-line therapy for mRCC	46
COVID can’t kill CopMich collaboration	44
A non-invasive assay for UTUC diagnosis	44
Vaccination to prevent untreatable gonorrhoea	44
Pain management in percutaneous nephrolithotomy — an approach rooted in pathophysiology	42
Personalized 3D models for prostate cancer surgery	42
Quest for a genetic biomarker for sickle cell disease priapism: rationale, progress and implications	41
Efficacy of the Revi system in treating urgency urinary incontinence	41
PEACEing together prostate cancer therapy	39
EMUC25: shaping tomorrow’s uro-oncology care	39
Resolving the puzzle of same-sex sexual interactions	39
Persistent Müllerian duct syndrome — a rare but important cause of male factor infertility	38
Measuring and improving the cradle-to-grave environmental performance of urological procedures	36
Bioinformatics in urology — molecular characterization of pathophysiology and response to treatment	35
Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway	34
Transitional urology: a comprehensive review of the transitional care process	34
Effect of high glucose on E. coli	33
The mechanism of action of neuromodulation in the treatment of overactive bladder	33
Rucaparib improves PFS in patients with BRCA1/2-altered mCRPC	32
The magic of MagSToNE	31
Secondary kidney stones — remove or leave?	30
A distinct TAM subset mediates immunotherapy resistance in prostate cancer	29
Women in urology: the past	29
Cribriform morphology affects mpMRI imaging	29
Promising efficacy of UTI vaccines as an alternative to antibiotics	27
AUA returns to its former glory in Chicago	27
Prostate cancer in transgender women — challenges in research and clinical care	26
Technical modifications to improve erectile function recovery after radical prostatectomy	26
Robots learning to imitate surgeons — challenges and possibilities	26
Microultrasonography-guided prostate cancer biopsy	25
Videourodynamics — role, benefits and optimal practice	25
Author Correction: Can PROMs improve racial equity in outcomes after prostatectomy?	24
A clinical overview of people living with HIV and genitourinary cancer care	24
Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease	24
Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer	23
Successful mentorship for women in urology — a new era	23
Current and emerging strategies to curb antibiotic-resistant urinary tract infections	23
Excluding PLND in favourable intermediate-risk prostate cancer: a PSMA-PET-directed perspective	23
Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards	23
Is it time to rethink the current patient-reported outcome measures?	23
Evolving language reflects evolving understanding: updated terms for anatomical description in i/VSC/DSD	22
Going in circles: circMGA–HNRNPL feedback loop in bladder cancer	22
Detecting lymph node metastases for personalized radiotherapy in patients with prostate cancer	22
Pride, not prejudice	21
Turning up the heat: CTLA4 blockade in urothelial cancer	20

Overall survival with adjuvant pembrolizumab in renal cell carcinoma — the shock of the lightning	20
AI for antibiotic design	20
Beyond maternal exercise: paternal exercise adaptations mediated by sperm microRNA signatures	19
Fathers matter too: sperm-borne epigenetic messages link paternal exposures to next-generation health	19
Androgen receptor pathway inhibitor combination in prostate cancer	19
Management and cost of stent encrustation in pregnancy	18
Immune-based therapies in penile cancer	17
The future of patient-derived xenografts in prostate cancer research	17
The prognostic role of stroma in UTUC	16
The evolving treatment landscape of metastatic urothelial cancer	16
De-clear cell differentiated renal cell carcinoma — a new therapeutic target	16
Turning back time in the testes	15
The shifting treatment paradigm of metastatic renal cell carcinoma	15
Uncovering a link between COVID-19 and renal cell carcinoma	15
Breaking the silence: normalizing receptive anal intercourse for patients, for people and for myself	15
The value of women urologists — individual and institutional imperatives to address salary equity	15
We all get erections — de-gendering sexual arousal dysfunction in the ICD	15
Och AI the noo from SIU	14
Improved phenotypic classification of male infertility to promote discovery of genetic causes	14
Urinary tract infections in children	14
Pelvic-fascia-sparing techniques and outcomes with RARP	14
The unclear role of PET–CT in localized radiorecurrent prostate cancer	13
Vitamins as regulators of calcium-containing kidney stones — new perspectives on the role of the gut microbiome	13
Men hold the balance of power	12
Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer	12
Hallmark discoveries in the biology of Wilms tumour	12
New evidence and novel techniques for assessing intraoperative margins during radical prostatectomy	12
Current and future pharmacotherapy for female sexual dysfunction	12
Effects of COVID-19 vaccine on semen parameters	11
Tuft cells in prostate cancer	11
Power up to investigate PrEP	11
ARNEO: neoadjuvant degarelix + apalutamide before surgery for high-risk prostate cancer	11
CMA mediates resistance to androgen inhibitors in prostate cancer	11
BAUSing back in Birmingham	11
A prompt-based stewardship to reduce extended-spectrum antibiotic treatment in UTI	10
Male infertility and somatic health — insights into lipid damage as a mechanistic link	10
Metabolism, mitochondria and metastasis in kidney cancer	10
Mechanisms of the intestinal and urinary microbiome in kidney stone disease	10
Author Correction: Atypical intraductal proliferation in prostate biopsy — a diagnostic grey zone with clinical implications	10
Diagnosis of ccRCC	10
Semen parameters across testicular cancer stages	10
Spatiotemporal trends in human semen quality	10
Mellow yellow: BilR reduces bilirubin to urobilinogen	10
Advances in sliding clip renorrhaphy for partial nephrectomy	9
The ins and outs of penile erection	9
Pathophysiology and potential multimodal therapeutic strategies for IC/BPS	9
MRI diagnosis and radical prostatectomy outcomes	9
Chlorination by-products in drinking water — association with bladder cancer risk	9
Syphilis on the rise — a need for alternative therapies and vaccines	9
Stepping up to prevent bacterial vaginosis recurrence	9
Pronouns in English: a user’s guide	9
Sperm activity affected by endometriosis	9
Testosterone replacement therapy and spermatogenesis in reproductive age men	9
Clinical trial design for non-muscle-invasive bladder cancer	8
Visual clues — dermatological manifestations of sexually transmitted infections in men	8
Particulate matter leaves a bitter taste in testes	8
Influence of substance use on male reproductive health and offspring outcomes	8
Artificial intelligence in the management of prostate cancer	8
Smooth muscle cell plasticity in pelvic organ prolapse	8
A great gathering at the 4th Clinical and Scientific Advances in UTI conference	8
EAU26: innovation, patient care and a touch of mythology	7
Exploring the impact of lipid stress on sperm cytoskeleton: insights and prospects	7
Feasibility and potential of an MRI-based prostate cancer screening	7
Urology on a changing planet: links between climate change and urological disease	7
Prescribing clinician specialty influences adherence to PrEP	7
ADT intensification to treat biochemically recurrent prostate cancer	7
Genetic and biological drivers of prostate cancer disparities in Black men	7
The future of pelvic lymph node dissection for urological malignancies	7
Mutagenic effect of chemotherapy on sperm DNA and implications for family planning	7
Revisiting the dual role of androgens and oestrogens in mammalian sex differentiation with a focus on genitalia	7
Von Hippel–Lindau protein signalling in clear cell renal cell carcinoma	7
The effects of diet on prostate cancer outcomes	7
New insights into APOBEC-mediated mutagenesis in prostate cancer	6
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma	6
Pregnancy and parental leave in medicine and academia — a focus on urology	6
Sexual transfer of bacteria for forensic use	6
Gut microbiome’s effect on immunotherapy response	6
Being a non-native English speaker in science and medicine	6
Neurogenic lower urinary tract dysfunction in ageing men with spinal cord injury	6
An app for optimizing UTI screening	6

Publisher Correction: HER2 in urothelial cancer: clinical speed outpacing diagnostic clarity	6
The prostatic middle lobe: clinical significance, presentation and management	6
A urologist as a urological patient	5
Adjuvant immunotherapy for renal cell carcinoma: understanding complexity, embracing uncertainty, making a difference	5
Reply to ‘Management of very young fetuses with LUTO’	5
GDF15 blockade can reduce immunotherapy resistance in urothelial cancer	5
Non-human primates as a translational model for the study of male reproductive health	5
Should we screen for sleep apnoea in men with idiopathic infertility?	4
CRISPR–Cas9 potential for identifying novel therapeutic targets in muscle-invasive bladder cancer	4
SRD5A2 and emerging therapies in androgen-driven disorders	4
Metastasis development in non-muscle-invasive bladder cancer	4
Promoting the health of men of all backgrounds: educating ourselves to build trust and improve care	4
The effect of red blood cell disorders on male fertility and reproductive health	4
Patient-reported outcomes in metastatic renal cell carcinoma trials using combinations versus sunitinib as first-line treatment	4
A vagina on a chip to model microbiome–host interactions	4
Advancing perioperative care in MIBC: insights from NIAGARA	4
Optimizing cystoscopy and TURBT: enhanced imaging and artificial intelligence	4
Managing autonomic dysreflexia during urological care in individuals living with spinal cord injury	4
Landmarks in the evolution of prostate biopsy	4
PIONEER big data platform for prostate cancer: lessons for advancing future real-world evidence research	4
Iatrogenic upper urinary tract injuries during ureteroscopy for urolithiasis: a comprehensive review on incidence, mechanisms and preventative strategies	4
Prostate cancer epigenetics — from pathophysiology to clinical application	4
Metabolic alterations drive enzalutamide resistance	4
The testosterone paradox of advanced prostate cancer: mechanistic insights and clinical implications	4
Understanding and integrating cytoreductive nephrectomy with immune checkpoint inhibitors in the management of metastatic RCC	3
A new surgical procedure to treat BPH	3
Author Correction: Advances in sliding clip renorrhaphy for partial nephrectomy	3
Immunoliposome targeting IL-30	3
Mapping the human prostate at the cellular level	3
The opportunities and barriers for developing tumour-infiltrating lymphocyte therapy for patients with advanced genitourinary cancers	3
Accessing information in the AI age	3
Proteomic characterization of bladder cancer	3
Control of oncogenic signalling in ccRCC	3
Clinical hypnosis improves LUTS	3
Knockout of extended pelvic lymph node dissection during radical cystectomy	3
Human sperm RNA in male infertility	3
Exercise, diet and psychological support for patients with testicular cancer	3
Emerging evidence for sequencing and combining PSMA-based therapies in prostate cancer	3
Targeting TGCT	3
Evolving the surgical approach for bladder cancer — robotic versus open radical cystectomy	3
Health-related quality of life after curative treatment for muscle-invasive bladder cancer	3
Can systematic biopsy be omitted from the prostate cancer diagnostic pathway?	3
Generative AI in scientific publishing: disruptive or destructive?	3
Perspectives on chemsex	3
The potential role of the microbiota in prostate cancer pathogenesis and treatment	3
From foes to friends: rethinking the role of lymph nodes in prostate cancer	3
Utility of PSA screening in transgender women receiving oestrogens	3
Microplastics in the penis	3
An epigenomic atlas for RCC	2
Better PrEParation for HIV prevention in minority groups	2
Artificial intelligence in academic writing: a paradigm-shifting technological advance	2
Patient-reported toxic effects of hypofractionated versus conventional RT	2
The dynamic roles of the bladder tumour microenvironment	2
Digital twins for personalized treatment in uro-oncology in the era of artificial intelligence	2
Key lessons from AI in other endoscopic disciplines to guide the future in cystoscopy	2
Robotic kidney transplantation	2
Abortion is a urology workforce issue	2
The burden of kidney transplant evaluation — an older adults’ perspective	2
Adjuvant personalized cancer vaccine: is this the end of metastatic kidney cancer	2
Does immune cell exhaustion lie at the heart of BCG-unresponsive disease?	2
EAU à la mode	2
PSMA-targeted fluorescence guidance for robotic-assisted prostatectomy	2
A multi-modal approach for decision making in bladder cancer	2
Metabolic flexibility in ccRCC	2
Body fluid-derived stem cells — an untapped stem cell source in genitourinary regeneration	2
Supplementary selenium and vitamin E in non-muscle-invasive bladder cancer	2
Intravesical ICIs to reduce toxicity in NMIBC	2
WGC in patients with localized prostate cancer	2
UPEC-mediated alteration of host mitochondrial function — a survival strategy	2
Enhancing spatial transcriptomics in clear-cell renal cell carcinoma	2
The urge to advance: ICS 2024 drives innovation in continence care	2
Electrical stimulation for the hypocontractile bladder	2
PROTACs for prostate cancer	2
The International Penile Prosthesis Implant Consensus Forum: clinical recommendations and surgical principles on the inflatable 3-piece penile prosthesis implant	2
Molecular and therapeutic landscape of non-clear cell renal carcinoma	2
Focusing on male infertility	2
Experimental in vitro, ex vivo and in vivo models in prostate cancer research	2
20 years of ‘spilling the tea’ in urology	2
Effects of the environment on the evolution of the vertebrate urinary tract	2
AI for drug discovery	2
ctDNA-guided treatment decisions in muscle-invasive bladder cancer	2
Road for inclusion and caring in urology starts at AUA 22	1
Potential role of oxidative stress in the pathogenesis of diabetic bladder dysfunction	1
Melon seed extract protects against testis metal toxicity	1
First-morning urine samples to study the urobiome	1
ML-guided decision for patient discharge location	1
A new signalling-based system for germ cell reprogramming	1
PSMA-PET to detect prostate cancer recurrence after radiotherapy	1
The yin and yang of chromosomal instability in prostate cancer	1
Modelling AR mutations	1
20 years of taxane therapy in prostate cancer — the past, present and future	1
Intralesional heterogeneity on PSMA PET–CT predicts mCRPC outcomes	1
Understanding and managing the cardiovascular risks of androgen deprivation therapy for prostate cancer	1
Temporary cessation versus continued TKI therapy for RCC	1
Immunoproteasome inhibition in CRPC	1